Erector Spinae Plane Block vs Trigger Point Injection for Chronic Thoracic Myofascial Pain
Official title: Ultrasound-guided Erector Spinae Plane (ESP) Block Versus Trigger Point Injection (TPI) for Chronic Thoracic Myofascial Pain: A Randomized Controlled Trial
Run by Mayo Clinic · NCT07632820 · Data updated 2026-11-12
A randomized trial tests whether an erector spinae plane (ESP) block or a trigger point injection (TPI) provides better relief for adults with chronic thoracic myofascial pain.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 76 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 5 sites (Jacksonville, Florida and 4 other locations) |
| Status | Recruiting |
| Started | August 13, 2026 |
| Main results expected | August 1, 2029 |
| Study ends | August 30, 2029 |
| Registry record updated | September 9, 2026 |
| Trial ID | NCT07632820 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 with chronic thoracic myofascial pain lasting at least three months and pain ≥4/10, with focal paraspinal findings or taut bands.
✕Probably not a fit
Some participants may not experience meaningful pain relief or improvement in function from either approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 4 interventional trial compares ESP block and TPI for chronic mid-back pain caused by muscle and connective tissue issues. Participants are randomly assigned to receive either ESP anesthesia with 0.5% plain bupivacaine or TPI with the same local anesthetic, and are followed for up to 12 weeks. Outcomes include pain relief, physical function, emotional well-being, patient satisfaction, and safety, collected via questionnaires and pain assessments. The study is conducted at Mayo Clinic sites and collaborating centers, with adults aged 18–80 who meet specific chronic pain criteria."
Why it matters
Potential benefit: If successful, the trial could identify a more effective injection approach for reducing pain and improving function in chronic thoracic myofascial pain.
How similar studies have gone: Previous studies have explored ESP blocks and TPIs separately, but direct head-to-head comparisons for this condition are limited and the evidence base is evolving.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18-80 years * Chronic thoracic myofascial pain lasting at least three months * Pain intensity of ≥4 on 11-point NRS * At least two of three following conditions: Focal thoracic paraspinal pain, palpable taut band, referred pain pattern with palpation Exclusion Criteria: * Thoracic radiculopathy * Cervical myelopathy with neurological deficit * Prior cervicothoracic spine surgery * Pregnancy or lactation * Contraindication to local anesthetic * Active malignancy * Fibromyalgia * BMI \>40 kg/m2 * Workers' compensation or active litigation related to thoracic pain * Acute herpes zoster or history of postherpetic neuralgia involving thoracic dermatomes * Current opioid use \>50 morphine milligram equivalents daily * Severe psychiatric or cognitive disorders, specifically history of schizophrenia, chronic psychotic disorders, dementia * History of substance use disorder * Inability to provide informed consent
Where it's running
-
Mayo Clinic
Rochester, Minnesota, United States Recruiting -
Mayo Clinic
Jacksonville, Florida, United States Not yet recruiting -
University of Maryland
Baltimore, Maryland, United States Not yet recruiting -
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States Not yet recruiting -
MD Anderson Cancer Center
Houston, Texas, United States Not yet recruiting
Study contacts
- Principal investigator: Ryan D'Souza, MD — Mayo Clinic
- Study coordinator: Ryan D'Souza, MD
- Email: dsouza.ryan@mayo.edu
- Phone: 507-284-9696
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ESPB for persistent back pain in ankylosing spondylitis
This trial tests whether an erector spinae plane block can help reduce persistent back pain in adults with ankylosing spondylitis who still have pain despite controlled disease activity.
-
Transcutaneous Electrical Nerve Stimulation for Acute Low Back Pain in EDs
This trial tests whether TENS can relieve acute low back pain in adults who come to the emergency department.
-
Hormones, Pain, and Exercise: Sports Bras for Full-Busted Women
This study tests whether specially designed sports bras can reduce neck, shoulder, arm, and back pain in full-busted women, and whether hormones, inflammation, or brain changes affect pain.
-
Mindfulness-based stress reduction for chronic thoracic or lumbar back pain
This project will test whether an 8-week mindfulness-based stress reduction (MBSR) course helps working-age adults (18–64) with chronic thoracic or lumbar back pain reduce their pain compared with usual care.
-
Pulsed vs Conventional Radiofrequency for Tailbone Pain
This study tests whether pulsed or conventional radiofrequency ablation of the ganglion impar better relieves tailbone (coccydynia) pain and improves sleep and quality of life in adults who have not responded to other treatments.
-
Psychological Options for Wellness and Recovery (POWeR) for Veterans with Chronic Back or Neck Pain
This study tests whether Pain Reprocessing Therapy (PRT), cognitive behavioral therapy (CBT), or usual care works best to lower pain in veterans with chronic back or neck pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.